Related Experiment Video
Updated: Jul 10, 2026

08:33
An Ex vivo Culture System to Study Thyroid Development
Published on: June 6, 2014
Abnormal thyroid function test results in patients with Fisher-Evans syndrome
Journal of Endocrinological Investigation
|March 1, 1993
Summary
Fisher-Evans syndrome (FES) patients show a higher prevalence of autoimmune hypothyroidism and thyroid autoantibodies compared to those with autoimmune hemolytic anemia (AIHA) or idiopathic thrombocytopenic purpura (ITP). This suggests FES may be part of a multiple autoimmune syndrome.
Area of Science:
- Endocrinology
- Immunology
- Hematology
Background:
- Fisher-Evans syndrome (FES) is a rare autoimmune disorder.
- Autoimmune hemolytic anemia (AIHA) and idiopathic thrombocytopenic purpura (ITP) are other autoimmune conditions.
- Thyroid dysfunction is common in autoimmune diseases.
Purpose of the Study:
- To evaluate thyroid function in FES patients.
- To compare thyroid abnormalities in FES, AIHA, and ITP.
- To investigate the association between FES and autoimmune thyroid disease.
Main Methods:
- Assessed thyroid function tests and autoantibodies in 20 FES, 44 AIHA, and 20 ITP patients.
- Analyzed prevalence of thyroid dysfunction and autoantibodies across the groups.
Main Results:
- Abnormal thyroid function observed in 40% of FES, 25% of AIHA, and 10% of ITP patients.
- Antithyroid antibodies (ATA) prevalence was 25% in FES, higher than in AIHA (11.4%) or ITP (0%).
- Subclinical hypothyroidism (20%) and hyperthyroxinemia (10%) were noted in FES, with 75% of hypothyroid cases positive for ATA.
Conclusions:
- Confirms high prevalence of thyroid abnormalities in AIHA, ITP, and FES.
- Demonstrates a higher prevalence of autoimmune hypothyroidism in FES.
- Suggests FES could be considered within the spectrum of multiple autoimmune syndromes.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

